Midven Strolll
Medical technology company Strolll has secured £2.1 million of investment.

Software developer for Parkinson’s disease wins £2.1m investment

1 min read

A digital therapeutics software developer has attracted £2.1 million of investment which will help its work improving the quality of life for people with neurological disorders.

Medical technology company Strolll, based in Lichfield, has secured £750,000 from the Midlands Engine Investment Fund (MEIF) through the MEIF West Midlands Equity Fund.

This funding forms part of a larger £2.1 million seed investment round led by MEIF fund manager Midven, part of the Future Planet Capital Group, in participation with Martlet Capital, SFC Capital, and multiple angel investors.

The funding will allow the company to reach several key milestones, including gathering outcomes data from ongoing studies and NHS pilots, expanding into the US market, and demonstrating the ability to apply the technology beyond Parkinson’s disease to other conditions.

Strolll develops digital therapeutics software for commercially available augmented reality glasses, which transforms physiotherapy and rehabilitation for people living with neurological disorders.

The patented software uses proprietary methods to alleviate gait and balance motor symptoms experienced by a large number of people with Parkinsons. The solution also has potential applications in rehabilitation of other neurological disorders, such as strokes and multiple sclerosis.

The tech-driven solution provides gamified exercise therapy through targeted, clinically-proven augmented reality activities. It allows patients to access rehabilitation exercise at home and maintain their disease at a lower stage for longer. This improves mobility, confidence, and independence which could reduce the long-term cost burden on families and healthcare systems.

Strolll CEO Jorgen Ellis said: “We are excited to use this funding to expand the capabilities of Strolll and look forward to working with Midven, and our investors and partners to make this a reality.

“With this investment, we aim to provide an accessible and effective solution for more patients with neurological disorders, ultimately improving their quality of life.”

Huw Sparkes, Junior Investment Manager at Midven, said:“We are thrilled to support Strolll in its mission to transform the lives of people with Parkinson’s disease and relieve strains on the NHS through innovative technology.

“Its dedication to improving the quality of life for those affected by this debilitating disease is truly inspiring.

“We look forward to supporting the business growth and further establishing its presence in the UK and backing its expansion worldwide.”

Alun Rogers, Chair of the Stoke-on-Trent and Staffordshire Local Enterprise Partnership, added: “We are very pleased to see an exciting digital therapeutics business secure funding through the Midlands Engine Investment Fund.

“The significant investment received not only highlights the potential of Strolll’s ground-breaking augmented reality software, but also showcases the strength of the West Midlands as a hub for innovation and MedTech.”

Hayley Johnson

Senior journalist with over 15 years’ experience writing for customers and audiences all over the world. Previous work has included everything from breaking news for national newspapers to complex business stories, in-depth human-interest features and celebrity interviews - and most things in between.

Latest from Blog